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A key role for gp130 expressed on peripheral sensory nerves in
pathological pain
Abstract
Interleukin-6 (IL-6) is a key mediator of inflammation. Inhibitors of IL-6 or of its signal transducing
receptor gp130 constitute a novel class of anti-inflammatory drugs, which raise great hopes for
improved treatments of painful inflammatory diseases such as rheumatoid arthritis. IL-6 and gp130 may
enhance pain not only indirectly through their proinflammatory actions but also through a direct action
on nociceptors (i.e., on neurons activated by painful stimuli). We found indeed that the IL-6/gp130
ligand-receptor complex induced heat hypersensitivity both in vitro and in vivo. This process was
mediated by activation of PKC-delta via Gab1/2/PI(3)K and subsequent regulation of TRPV1, a member
of the transient receptor potential (TRP) family of ion channels. To assess the relevance of this direct
pain promoting effect of IL-6, we generated conditional knock-out mice, which lack gp130 specifically
in nociceptors, and tested them in models of inflammatory and tumor-induced pain. These mice showed
significantly reduced levels of inflammatory and tumor-induced pain but no changes in immune
reactions or tumor growth. Our results uncover the significance of gp130 expressed in peripheral pain
sensing neurons in the pathophysiology of major clinical pain disorders and suggest their use as novel
pain relieving agents in inflammatory and tumor pain.
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Interleukin-6 (IL-6) is a key mediator of inflammation. Inhibitors of IL-6 or of its signal transducing receptor gp130 constitute a novel
class of anti-inflammatory drugs, which raise great hopes for improved treatments of painful inflammatory diseases such as rheumatoid
arthritis. IL-6 and gp130may enhance pain not only indirectly through their proinflammatory actions but also through a direct action on
nociceptors (i.e., on neurons activated by painful stimuli). We found indeed that the IL-6/gp130 ligand-receptor complex induced heat
hypersensitivity both in vitro and in vivo. This process wasmediated by activation of PKC- via Gab1/2/PI3K and subsequent regulation
ofTRPV1, amemberof the transient receptorpotential (TRP) family of ion channels. To assess the relevanceof this direct painpromoting
effect of IL-6, we generated conditional knock-out mice, which lack gp130 specifically in nociceptors, and tested them in models of
inflammatory and tumor-induced pain. These mice showed significantly reduced levels of inflammatory and tumor-induced pain but no
changes inimmunereactionsortumorgrowth.Ourresultsuncoverthesignificanceofgp130expressedinperipheralpainsensingneuronsinthe
pathophysiology ofmajor clinical pain disorders and suggest their use as novel pain relieving agents in inflammatory and tumor pain.
Introduction
Painmanagement in conditions of chronic inflammation, such as
rheumatoid arthritis (RA), remains a major clinical challenge. A
large body of preclinical studies has been dedicated toward deci-
phering the pathophysiological sequelae of events occurring in
immune cells during chronic inflammation. However, from the
perspective of understanding chronic pain arising in these states,
it is also important to understand and address bilateral interac-
tions between immune cells and sensory nerves. Locally released
cytokines are a key class of molecules which are particularly rel-
evant in this context. Several lines of evidence show that cytokines
play a key role in the pathophysiology of inflammation. A variety
of key cytokines, e.g., interleukin-6 (IL-6), IL-11, leukemia
inhibitory factor (LIF), oncostatinM (OSM), ciliary neurotro-
phic factor (CNTF), and cardiotropin-1 (CT-1), use the signal
transducer glycoprotein 130 (gp130) for signaling onto mast
cells, macrophages, and other types of immune cells (Yoshida
et al., 1996; Betz et al., 1998).
Of these, the pleiotropic cytokine IL-6 is particularly worth
noting because its levels in healthy individuals are very low, but
dramatically elevated in painful inflammatory conditions (Kiefer
et al., 2001; Smith et al., 2001). In rats, a direct injection of IL-6
causes hypersensitivity to thermal andmechanical stimuli (Poole
et al., 1995;Oka et al., 1995;DeLeo et al., 1996; Brenn et al., 2007).
IL-6 complexes with membrane-bound or soluble IL-6 receptor,
IL-6R, to activate cells expressing the signal transducer glycopro-
tein gp130 (Taga et al., 1989; Rose-John and Heinrich, 1994).
Interestingly, most cells are devoid of membrane-bound IL-6R
and are thus unresponsive to the cytokine IL-6. Such cells, how-
ever, can still react to IL-6 complexed with a soluble form of
the IL-6R (sIL-6R) to activate gp130, a pathway called “trans-
signaling” (Rose-John and Heinrich, 1994). Interestingly, the
sIL-6R is generated by apoptotic neutrophils during inflamma-
tory states (Chalaris et al., 2007). In addition to immune and
myeloid cells, gp130 is also expressed in rat sensory neurons
(Opre´e andKress, 2000; Gardiner et al., 2002;Obreja et al., 2002a,
2005). However, the functional role of gp130 expressed on sen-
sory nerves is not well understood. Furthermore, the signaling
events downstream of gp130 in sensory nerves have not been
explored, nor is it known how these may potentially impact on
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key nociceptive molecules, such as ion-channels involved in pain
transduction.
We hypothesized that gp130 expressed on sensory nerve may
be functionally linked to pathological pain. To specifically delin-
eate the functional role of cytokine signaling via gp130 in sensory
neurons, we used a conditional gene targeting approach in mice
based on selective deletion of gp130 fromperipheral sensory neu-
rons, leaving its expression in other cells intact. Our results sug-
gest that gp130 expressed in sensory nerves not only mediates
chronic inflammatory pain, but also contributes significantly to
complex interactions between immune cells, tumor cells, and
nerves in the context of cancer-evoked pain. Moreover, we iden-
tify IL-6 activating gp130, Gab1/Gab2, PI3K, and PKC- and reg-
ulating TRPV1 as a key mechanism linking cytokine release to
sensitization of pain-sensing nerves.
Materials andMethods
Genetically modified mice. Mice homozygous for the floxed allele of the
mouse Il6st gene (gp130 fl/fl), which encodes the interleukin-6 signal
transducer (Il6st, henceforth gp130) have been described previously
(Betz et al., 1998). gp130 fl/fl mice were cross-bred with SNS-Cre mice
(Agarwal et al., 2004) to obtain homozygous SNS-Cre gp130 fl/fl (SNS-
gp130/) and gp130 fl/fl mice (control littermates; the recombinase is
homo- or heterozygous). All mice were genotyped usingmouse genomic
tail DNA with sense primer 5-TGGCTTGAGCCTCAGCTTGG-
CTAG-3 and antisense primer 5-TGAACAGTCACCATGTACAT-
CTGTACGC-3 to detect the floxed gp130 allele, and sense primer
5-GAAAGCAGCCATGTCCAATTTACTGACCGTAC-3 and antisense
primer 5-GCGCGCCTGAAGATATAGAAGA-3 to detect SNS-Cre
transgene expression. SNS-Cremice, SNS-gp130/mice and their cor-
responding littermates [wild-type (wt) and gp130 fl/fl mice, respectively]
had the genetic background C57BL/6J. All mice were maintained under
SPF conditions. Littermates were used in all experiments to control for
background effects, and all animal use procedures were in accordance
with ethical guidelines and animal welfare standards according to Aus-
trian law. All behavioral measurements were done in awake, unre-
strained, age-matched mice that were8 weeks old by individuals who
were blinded to the genotype of the mice being analyzed.
Southern blot. Genomic DNA from wild-type, gp130 fl/fl and SNS-
gp130/mice dorsal root ganglia (DRGs)was cleaved overnight at 37°C
using EcoRI (Roche) in a 10 EcoRI buffer (Roche). DNA was separated
on a 0.7% agarose gel containing ethidium bromide, and then blotted
onto a nylon membrane (GeneScreen Plus, PerkinElmer Life Sciences)
and placed on aUV transilluminator (UV-Stratalinker 2400, Stratagene).
The gp130 genomic DNA probe was labeled with - 32P-dCTP (10.0
mCi/ml, PerkinElmer Life Sciences) using theMegaprimeDNALabeling
System (GE Healthcare). The membrane was prehybridized for 3 h at
50°C in a hybridization buffer containing 5 Denhardt’s solution (bo-
vine serum albumin (Sigma), polyvinylpyrrolidone (Sigma), Ficoll 400
(Sigma), 5 SSC, 1% (w/v) SDS (Sigma), and 100 g/ml degraded
salmon sperm DNA) (Sambrook and Russell, 2001). The probe was de-
natured, added to the hybridization buffer, and hybridized overnight at
50°C. The membrane was then briefly washed in 2 SSC/0.1% SDS at
50°C followed by 2 SSC/0.1%SDS 2 30min at 50°C and then in 0.1
SSC/0.1% SDS for 10 min at 50°C. Results were examined after exposure
to X-ray film (GE Healthcare).
Qualitative and quantitative PCR. Qualitative PCR was performed,
respectively, on RNA, cDNA, isolated frommurine dorsal root ganglion
(DRG) neurons, treated with TRI Reagent (Sigma), restricted with
DNase I (Fermentas), and reverse transcribed withMuLV Reverse Tran-
scriptase (Applied Biosystems). Specific PCR primers were picked ac-
cording to NCBI referenced sequences. Primer Express Software,
Version 3.0 (Applied Biosystems) was used to define primer base consti-
tution, length, and melting temperatures. Oligonucleotides were pur-
chased atMWG (EurofinsMWGOperon). The following sets of primers
were used: set 1, sense primer 5-GATAACCTGCTCTGGGTGGA-3,
antisense primer 5-TGGAGTTAAAATTGTG CCTTGG-3; set 2, sense
primer 5-ACCAGATTCCTGTGGACGAC-3, antisense primer 5-
TGACCACTGGGCAATATGAC-3. The presence of the desired muta-
tion in the resulting fragments of 400 bp (wild type, gp130 fl/fl) and 300 bp
(SNS-gp130/) was confirmed by sequencing (Microsynth AG). The
cycle protocol of the first PCR consists of 1 min at 94°C, 20 three-step
cycles of 30 s each at 94°C, 60 s each at 57°C, and 120 s each at 72°C, and
a final extension at 72°C of 10 min. The nested PCR was done as afore-
mentioned; only the number of cycles was adjusted to 30. For analysis of
gene expression levels, respectively mRNA levels, total RNA was isolated
from murine DRG neurons of untreated and treated animals immedi-
ately after preparation by using TRI Reagent (Sigma) according to the
manufacturer’s instructions. RNAwas treatedwithDNase I (Fermentas).
Reverse transcription to cDNAwas performed using the GeneAmp RNA
PCR Kit (Applied Biosystems). Each cDNA sample was analyzed for
expression of gp130 by quantitative real-time PCR using the TaqMan 5
nuclease assays Mm01297292_m1 (gp130, exon boundary 16–17),
Mm0129298_m1 (gp130, exon boundary 8–9) and Mm01352363_m1
(Succinate Dehydrogenase Subunit A, SDHA). In case of exon 15 (trans-
membrane region) a MGB probe (5-TGTGCTTAGCCTTCC-3) and
the primers 5-GAAATAGAAGCC-3 and 5-CCTGACAACCCTG-
CTGGGCGT-3, respectively (all Applied Biosystems), were used. Reac-
tions were performed in a MicroAmp Fast Optical 96-Well Reaction
Plate (Applied Biosystems) using the 7500 Fast Real-Time PCR System
(Applied Biosystems) for thermal cycling and real-time fluorescence
measurements. The PCR cycle protocol consisted of 10 min at 95°C, and
40 two-step cycles of 15 s each at 95°C and of 1 min at 60°. Positive and
negative controls were included in all the experiments and each sample
was run in triplicate for each PCR. Threshold cycle (CT) values were
recorded as a measure of initial template concentration. Relative fold
changes in RNA levels were calculated by theCTmethod using SDHA
as a reference standard. The range for the target, relative to a calibrator
sample was calculated by 2CT.
Culture of primary sensory neurons. Lumbar DRGs with the cell bodies
of primary afferents that project into the hindpaw were harvested from
adult mice as previously published (Obreja et al., 2002b; Agarwal et al.,
2007). After removal of the connective tissue, ganglia were incubated in
Liberase Blendzyme 1 (9 mg/100 ml DMEM, Roche) for 60 min. After
washing with PBS (PAA), 1 Trypsin-EDTA (Invitrogen) was added for
30 min, and DRGs were washed TNB medium (Biochrom) containing
L-glutamin (Invitrogen), penicillin G sodium, streptomycin sulfate (In-
vitrogen), and a Protein-Lipid-Komplex (Biochrom). The DRGs were
triturated with a fire-polished Pasteur pipette and centrifuged through a
3.5% BSA gradient (Sigma). The sensory neurons were resuspended,
plated on coverslips coated with polylysine/laminin (Sigma), and culti-
vated in supplemented TNB containing mNGF (Alomone Labs, 10 g/
100 ml TNB-medium) at 37°C in 5% CO2 for 24–36 h.
Culture of tumor cells. Lung carcinoma cells (ETCC clone 1642, Euro-
pean Type Cell Culture Collection) were cultivated in DMEM with
L-glutamine and 10% fetal bovine serum (FBS). Before injection, cells
were counted, washed twice, and then resuspended in PBS (25 l). Mice
were anesthetized with isofluorane (Baxter) and 7 105 lung carcinoma
cells were injected subcutaneously in the plantar and dorsal side of the
mouse hindpaw.
Immunocytochemistry and live cell labeling.DRG neurons were disso-
ciated according to the protocol and plated on coverslips. After 24 h in
culture, neurons were fixed with 4% PFA for 20 min, permeabilized
with 0.01% TX-100 (Sigma) for 2 min and blocked with blocking
buffer (BB, 10% goat serum in PBS) for 30 min. Cells were incubated
with primary antibodies diluted in BB (1:200) for 1 h at room temperature
(RT), washed with PBS, and incubated with secondary antibodies (1:1000)
for 30 min at RT. Nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI, 1:10,000 in PBS) and cells were embedded in
Mowiol (Calbiochem). Cell counting was performed at least from
triplicates of the experiments. For live cell labeling DRG neurons were
incubated on ice with the primary antibody diluted in TNB medium
(1:50) for 30 min, washed with TNB medium for 10 min on ice, and
incubated with the secondary antibody diluted in TNB medium (1:
1000). Subsequently cells were fixed with 4% PFA and proceeded to
immunohistochemistry.
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Immunohistochemistry on frozen sections.DRGs were washed with PBS
and fixed with 4% PFA for 20 min. After 3 10 min washing with PBS,
ganglia were frozen in methylbutan. Sections (12 m) were cut with a
Leica CM 1850 Cryomicrotome, permeabilized with 0.1% TX-100, and
blocked with blocking buffer. Sections were incubated with primary an-
tibodies overnight at 4°C in a wet chamber. After washing in PBS,
sections were incubated with the secondary antibodies, and embedded in
Mowiol (Calbiochem). Indirect immune fluorescence was detected with
a Zeiss Axiovert 200M microscope and analyzed with the MetaMorph
Imaging Software Series 7.1 (Molecular Devices, Visitron Systems). The
following antibodies were used: anti-gp130 (1:50, extracellular epitope,
Neuromics); anti-Nav1.8 (1:200, was a generous gift fromProf. Dr. H. G.
Knaus, Innsbruck, Austria) (see also supplemental Fig. 2, available at
www.jneurosci.org as supplemental material) (Liu et al., 2006); anti-
CGRP (1:300, ImmunoStar), anti-Isolectin IB4 (1:1000, Invitrogen);
Alexa Fluor 488 goat anti-rabbit IgG (1:1000, HL), Alexa Fluor 594,
donkey anti-goat IgG (1:1000, all Invitrogen).
Western blotting. Sensory neurons were plated on poly-L-lysine/
laminin-coated dishes, kept in culture for 24 h, stimulated with 5 ng/ml
HIL-6 for 10min in extracellular solution (ECS), and harvested in freshly
prepared ice-cold lysis RIPA-buffer (50 mM Tris-HCl, 150 mM NaCl, 50
mM NaF, 5 mM EDTA, 0.5% Deoxycholic Acid, 0.1% SDS, 1% Nonidet
P-40, all Sigma). The phosphatase inhibitors sodium-orthovanadate
(200 M) and -glycerophosphate (40 mM, both Sigma) were added to
keep the proteins in phosphorylated state. A protease-inhibitor cocktail
(Sigma) was used to protect proteins from proteolysis. SDS-PAGE was
performed under standard denaturing conditions using 8.3  7.3 cm
handcast gels (Mini-PROTEAN, Bio-Rad Laboratories). Equal amounts
of protein were loaded to each lane of 10% polyacrylamide gels. Spectra
Multicolor Broad Range Protein Ladder (Fermentas) was used as a
molecular weight standard. Gels were blotted immediately after electro-
phoresis onto polyvinylidene fluoride membrane (Hybond-P, GE
Healthcare). For immunodetection, membranes were blocked for 1.5 h
with 5% (w/v) nonfat drymilk or 5% (w/v) BSA and 0.1% (v/v) Tween 20
in Tris-buffered saline, pH 7.6, at room temperature, and processed ac-
cording to the instructions of the manufacturers of the antibodies. The
following antibodies were used: anti-tubulin (Sigma), anti-phospho-
Gab1(Tyr307), anti-phospho-Gab2(Tyr502), anti-phospho-PI3K p85
(Tyr458)/p55 (Tyr199) (all Cell Signaling Technology), anti-Gab1 (H-
198), and anti-Gab2 (I-18) (both Santa Cruz Biotechnology). Visualiza-
tion of blots was performed with enhanced chemiluminescence by using
the ECLPlus Western Blotting Detection System (GE Healthcare).
Translocation of PKC-. Cultured neurons were stimulated with 5
ng/ml HIL-6 in ECS for 10 min, fixed in 4% PFA for 20 min, permeabil-
ized in 0.2% TX-100 for 5min, blocked with 10%NGS, and stained with
anti-PKC (BD Transduction Laboratories). Images were obtained by a
Zeiss Axiovert 200 M laser confocal microscope LCM 510. To quantify
the redistribution of PKC- after stimulation, line scan profiles of fluo-
rescence intensities were recorded with the MetaMorph Imaging Series
7.1 Software (Visitron Systems). The total length of the profile along the
diameter of the cell was set to 100%, and fluorescence intensities of the
profile between 0 and 10% and 90 and 100% were determined (periph-
ery) together with intensities between 45 and 55% of the profile (cen-
ter of cell). The translocation coefficient (K) was calculated as ratio of
the values determined for the average of the periphery divided by the
value within the center of the cell as previously published (Rathee et
al., 2002). K  1 if the enzyme is equally distributed throughout the
cell, K  1 refers to predominant localization close to the plasma
membrane, and K  1 represents a predominantly cytoplasmic
localization.
Patch-clamp recordings.DRGneurons in culture were used for electro-
physiology after 24 h. Whole-cell ionic currents were recorded from
isolated neurons in thewhole-cell configuration of the patch-clamp tech-
nique as previously published (Obreja et al., 2002b, 2005). ECS contained
(inmM): 150NaCl, 5 KCl, 0.1 CaCl2, 1MgCl2 (all Sigma), 10 glucose, and
10 HEPES (Merck), at pH 7.3 adjusted with NaOH (Merck). Calcium
was reduced to 0.1 mM to avoid desensitization of capsaicin-induced
currents. Borosilicate glass pipettes (Science Products) pulled with a hor-
izontal puller (Sutter Instruments Company) were filled with internal
solution (ICS) (inmM): 148 KCl, 2MgCl2, 2 Na-ATP, 0.1 CaCl2, 1 EGTA
(all Sigma), and 10 HEPES (Merck), at pH 7.3 adjusted with KOH
(Merck). After filling, electrode resistance was 4–5 M	. Neurons were
clamped at80mV holding potential. Currents were filtered at 2.9 kHz,
sampled at 3 kHz, and recorded with an EPC 9 (HEKA) and the Pulse
v8.74 software (HEKA). Experiments were performed at room tempera-
ture and only one neuron was tested per Petri dish. A seven barrel system
with common outlet was used for fast drug administration and heat
stimulation of single neurons (Dittert et al., 1998). Capsaicin-activated
inward currents (Icaps) were elicited by applying 0.3 M capsaicin
(Sigma) for 10 s followed by a 2 min washout with control solution. This
protocol was repeated 3 times before HIL-6 (1 ng/ml) was applied for 1
min immediately before capsaicin for conditioning stimulation. Recom-
binant interleukin-6 from mouse (IL-6, Sigma) was solved in PBS con-
taining 10% BSA. IL-6 (5 ng/ml) and BSA (vehicle; 0.1 mg/ml),
respectively, were used in the extracellular solution.
Skin-nerve preparation and single fiber recordings.An in vitro skin nerve
preparation was used to investigate the properties of the afferent nerve
fibers innervating the skin of the mouse dorsal hindpaw as previously
published (Kress et al., 1992; Koltzenburg et al., 1997). Briefly, the prep-
aration was superfused (15 ml/min) with an oxygen-saturated modified
synthetic interstitial fluid solution containing (in mM) 108 NaCl, 3.48
KCl, 3.5 MgSO4, 26 NaHCO3, 1.7 NaH2PO4, 2.0 CaCl2, 9.6 sodium
gluconate, 5.5 glucose, 7.6 sucrose at temperatureof 31
1°C, andpH7.4

0.05. Action potentials of single sensory neurons were recorded extracel-
lulary from fine filaments dissected from the saphenous nerve, amplified
(5000-fold), filtered (low pass 1 KHz, high pass 100 Hz), visualized on
oscilloscope, and stored on a PC-type computer with Spike/Spidi soft-
ware package (Forster and Handwerker, 1990). The fibers were charac-
terized as unmyelinated (C) according to their conduction velocity
(c.v. 1.4 m/s). The receptive field was identified bymechanical prob-
ing of the skin with a glass rod; standard heat stimuli linearly rising the
intracutaneous temperature from 31
 1°C to 47°C were applied. A fiber
was considered heat sensitive if 3 or more action potentials were evoked
during the stimulus. The heat threshold was defined as the temperature
that elicited the third spike of the response. In tumor-injected mice elec-
trophysiological recordings were performed 7–10 d after inoculation
when a tumor mass had formed at the injection site.
Electron microscopy. SNS-gp130/ and the corresponding gp130 fl/fl
control mice were transcardially perfused with cacodylate buffer con-
taining 2% freshly depolymerized paraformaldehyde and 2% glutar-
dialdehyde, followed by femoral nerve dissection, osmification, and
embedding in Spurrs medium as described previously (Carenini et al.,
2001). Ultrathin sections (80 nm) were contrasted with lead citrate and
analyzed using a ProScan Slow Scan CCD (Proscan) camera mounted to
a Leo 906 E electron microscope (Zeiss) and corresponding software
iTEM (Olympus).
Slice recordings. Spinal cord slices of 14 – 20-d-old mice were obtained
by a standard procedure. In short, themicewere anesthetizedwith isoflu-
rane and decapitated, the spinal cord was microdissected in ice-cold
ACSF (containing 125 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4,
2.5mMKCl, 2mMCaCl2, 1mMMgCl2, 10mM glucose), glued to a gelatin
block, and frontal slices were obtained by a vibroslicer. Lumbar slices
with intact dorsal rootlets were fixed in a recording chamber with a
platinum grid and a bipolar stimulation electrode (250 m pole dis-
tance) was placed on both sides of the rootlet. Synaptic currents of dorsal
horn neurons (layer 2/3) in response to stimulation of the primary affer-
ents with short pulses (0.2 ms duration, pulse distance 12 s) were re-
cordedwith anEPC10 andpatchmaster software (HEKA)byuse of patch
pipettes filled with a K-gluconate-based internal solution (Cl reversal
potential90mV). The stimulation threshold was identified as the low-
est voltage strength with a response probability50%.
Behavioral testing. Standard testing procedures were used to quantify
signs of pain-like behavior. The area tested was the plantar side of the
hindpaw where the tumor cells were inoculated. Heat sensitivity was
assessed using the Hargreaves test (Hargreaves et al., 1988). Paw with-
drawal latency in response to an increasing heat stimulus was measured
automatically (Ugo Basile) before and after cytokine injection or tumor
cell injection at time points as indicated in figures. Instead of coinjecting
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IL-6 together with sIL-6R, the designer peptide
hyper-IL-6 (HIL-6) was used to mimic the ef-
fects of the IL-6/sIL-6R complex (Fischer et al.,
1997). Complete Freund’s Adjuvant (CFA, 20
l, Sigma) was injected into the plantar site of
the hindpaw in gp130 fl/fl and SNS-gp130/
mice, and changes in the mechanical and heat
sensitivity were measured 6, 24, and 48 h after
inoculation. At the end of the observation pe-
riod, tumors were excised in toto, cleaned from
connective tissue, and weighed immediately.
For CCI of the right sciatic nerve, mice were
anesthetized by intraperitoneal phenobarbital
injection, and three ligatures (7-0 prolene)
with a distance of 1 mm each were loosely tied
around the nerve proximal to the trifurcation
until a short flick of the hindpawwas observed.
Statistical analysis. For detailed statistical
analysis the SigmaStat 3 program was used.
Data are presented as mean 
 SEM and were
analyzed using the Wilcoxon signed rank test,
the paired t test or one-way repeated-measures
ANOVA for comparison between groups and
test days, followed by a Student’s t test if not otherwise stated. Differences
were considered statistically significant at p 0.05.
Results
Animals deficient for the ubiquitously expressed signal trans-
ducer IL-6 receptor  subunit gp130 die after 12.5 d postconcep-
tion or postnatally, depending on the genetic background
(Yoshida et al., 1996; Kawasaki et al., 1997). Therefore, condi-
tional knock-out mice lacking gp130 selectively in nociceptive
neurons of the DRG were generated using the Cre recombinase
loxP strategy and conditional removal of the transmembrane
exon 15 (referred to henceforth as SNS-gp130/mice). This was
achieved by mating homozygous mice carrying the loxP-flanked
(floxed) gp130 allele (130 fl/fl) (Betz et al., 1998) with a mouse line
expressing Cre recombinase under the transcriptional control of
the nociceptor-specific Nav1.8 gene (SNS-Cre). In SNS-Cremice,
gene recombination selectively occurs in 90% of small size
(28m)nociceptive sensory neurons, commenced at birth and
does not affect gene expression in other regions (Agarwal et al.,
2004). Deletion of gp130 in DRG neurons was detected by South-
ern blot analysis on genomicDNAofmouseDRGs using a gp130-
specific probe and via quantitative PCR analysis (supplemental
Fig. 1, available at www.jneurosci.org as supplemental material).
To confirm that gp130 protein was absent from the cell mem-
brane, live immune staining was performed with antibodies di-
rected against the extracellular domain of gp130 and the Nav1.8
ion channel in neuron cultures obtained from gp130 fl/fl and SNS-
gp130/mice, which revealed that90%of theNav1.8-positive
neurons in SNS-gp130/mice did not show anti-gp130 immu-
noreactivity on their cell surface (Fig. 1A,B). Thus these three
independentmethods suggest an efficient recombination and de-
letion of functional gp130 in nociceptive neurons. In contrast,
expression of gp130 remained intact in other tissues, including
immune cells, in SNS-gp130/mice (data not shown).
No obvious developmental abnormalities occurred on loss of
gp130 from sensory neurons. Since cytokine signaling via gp130
such as IL-6 or LIF are important survival factors and also regu-
late neuronal excitability (Ma¨rz et al., 1999; Scha¨fer et al., 1999;
Brenn et al., 2007; Kawasaki et al., 2008), we assessed whether the
two main classes of nociceptive neurons in the DRG, namely the
peptidergic, CGRP-expressing (CGRP) and the nonpeptider-
gic, Isolectin B4 binding (IB4) nociceptors (Caterina and
Julius, 1999) were different fromwild-type littermates. Themor-
phology and the overall frequency of IB4 and CGRP neuron
populations were similar between wild-type and SNS-gp130/
DRGs (Fig. 2A,B,) suggesting that the lack of the gp130 signal
transducer did not affect the morphology or general structural
properties of sensory neurons. Electron microscopy revealed no
pathological alterations in nonmyelinated nerve fibers of SNS-
gp130/ mice (Fig. 2C,D). General morphology of the spinal
dorsal horn and electrophysiological parameters of synaptic spi-
nal transmission in the substantia gelatinosa were similar in both
mouse strains (supplemental Fig. 3A,B, available at www.
jneurosci.org as supplemental material). Overt motor or other
behavioral deficits were not observed in the SNS-gp130/mice
compared with littermates.
Functional consequences of gp130 loss from sensory neurons
No overt difference was observed regarding basal heat pain sen-
sitivity in mice lacking neuronal gp130. Since IL-6 is found at
high levels in inflamed tissue, we investigated SNS-gp130/
mice in a model of inflammation-induced hyperalgesia. Subcu-
taneous inoculation of 20 l of CFA (1 mg/ml) into the plantar
site of the hindpaw led to development of inflammation and
hypersensitivity to noxious heat stimulation, both in gp130 fl/fl
and SNS-gp130/ mice within 6 h after injection (Fig. 3A).
However, although the degree of swelling, which is an indication
of inflammation, was very similar in bothmouse strains (Fig. 3B),
the heat hyperalgesia was significantly attenuated in SNS-gp130/
compared with gp130fl/fl mice ( p 0.001, ANOVA). In gp130 fl/fl
mice, inflammatory hyperalgesia fully developed within 6 h and
remained at constant levels for up to 48 h. In contrast, after an
initial peak at 6 h, SNS-gp130/ showed significant recovery
from the hyperalgesic state, although inflammation persisted
(Fig. 3A).
Significance of neuronal gp130 for cancer pain
In a novel model for cancer pain inmice, we have recently shown
that on a subcutaneous injection of LL2 carcinoma cells into
hindpaw, the tumor stroma shows signs of an inflammatory re-
action and is densely invaded by macrophages, which are known
to produce large amounts of cytokines when activated (Constantin
et al., 2008). In this model, tumor growth is accompanied by
sprouting of peptidergic nerve fibers into the tumor mass, pro-
Figure 1. Small-size neurons from SNS-gp130/ lacked gp130 immunoreactivity but were otherwise normal. A, Double
labeling of SNS-gp130/ andgp130 fl/flDRGneuronswith anti-gp130 andanti-Nav1.8. Scale bar, 15m.B, Live imagingof DRG
neurons showed colabeling of gp130 immunoreactivity and Nav1.8 immunoreactivity in 90% of neurons from gp130
fl/flmice, but
lack of gp130 membrane immunoreactivity in 90% of Nav1.8-immunoreactive neurons in SNS-gp130
/mice.
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gressive mechanical and heat hyperalgesia, and a significant sen-
sitization of nociceptors in wt C57BL6J mice (Constantin et al.,
2008). As the tumors grew, a progressive heat hyperalgesia was
observed in gp130 fl/fl mice ( p  0.001, ANOVA, n  23) (Fig.
3C). In SNS-gp130/ mice, heat hyperalgesia was significantly
attenuated, andmild signs of heat hyperalgesia developed only in
the very late stages after tumor induction (Fig. 3D). This benefi-
cial effect was not due to a reduction of tumor growth or inflam-
mation because tumor growth and paw swelling were similar in
gp130 fl/fl and SNS-gp130/mice (Fig. 3G).
Neuronal gp130 required for tumor-associated
nociceptor sensitization
In wt C57BL6J mice, tumor-induced hyperalgesia is accompa-
nied by a sensitization of heat-sensitive nociceptive fibers inner-
vating the skin in the tumor area.We therefore hypothesized that
activation of neuronal gp130 might be critical for the nociceptor
sensitization process and performed single fiber recordings from
unmyelinated nociceptive primary afferents in a skin-nerve in
vitro preparation (Reeh, 1986; Koltzenburg et al., 1997). In vitro,
heat-sensitive unmyelinated fibers from gp130 fl/fl tumormice ex-
hibited higher mean discharge rates during heat stimuli com-
pared with fibers from control mice without tumor [4.53
 1.00
impulses (imp)/s versus 2.27 
 0.53 imp/s; p  0.05; ANOVA]
(Fig. 3E). In SNS-gp130/ mice with tumors, the mean heat
response magnitudes were similar to those in nociceptors re-
corded from naive healthy mice ( p 
0.05; ANOVA (Fig. 3F). This suggests that
gp130 expressed on nociceptive primary af-
ferents plays an important role in the gener-
ation of tumor-induced heat hyperalgesia
anddirectly regulates the sensitivity of pain-
sensing neurons. No major contribution of
gp130 was observed in a model of neuro-
pathic pain, in which the development of
heat hyperalgesia was delayed, but not pre-
vented.Thiswas likelydue to lackof amajor
inflammatory component in this model
(supplemental Fig. 4, available at www.
jneurosci.org as supplemental material).
Relevance of IL-6 for tumor-associated
pain and nociceptor sensitization
The above analyses suggest that gp130 ex-
pressed on sensory nerves plays a direct role
inpathophysiological processes triggeredby
cytokines in sensory nerves. To study in
depth which molecular events would func-
tionally link cytokine-induced gp130 to no-
ciceptivehypersensitivity,we turned to IL-6,
a key cytokine implicated in pathological in-
flammatory disorders and pain. In the tumor
material we also found expression of IL-6
mRNA,whichwasnotdetectedinLL2cellcul-
tures before injection into the paw (Fig. 4A),
suggesting an upregulation of IL-6 expression
in tumor cells or associated immune cells in
vivo. Correspondingly, we found significant
upregulation of IL-6 protein levels in the tu-
mor tissue compared with healthy control
tissue (e.g., skeletal muscle) (Fig. 4B).
In most tissues, IL-6 requires a ligand-
binding soluble receptor subunit (sIL-6R),
which complexes with the membrane-bound gp130 signaling sub-
unit.A recent studybyChalaris et al. showed thatneutrophils,which
normally precede the incomingmacrophages, are amajor source of
sIL-6R during inflammatory states (Chalaris et al., 2007). This sug-
gests that both IL-6 and sIL-6R are present in the tumor tissue. A
designer fusion peptide,HIL-6, has been shown to bind and activate
gp130 and to mimic IL-6/sIL-6R effects in many tissues (Fischer et
al., 1997).We usedHIL-6 as a tool to investigate whether activation
of gp130affects painbehavior inmice. InjectionofHIL-6 (1g in10
l) into the foot pad of a hindpaw in gp130fl/fl mice led to a signifi-
cant drop in paw withdrawal latencies (PWLs) to heat stimulation
from 8.89
 0.43 s before to 4.20
 0.43 s 30 min after inoculation
( p 0.001; ANOVA). PWL recovered to preinjection valueswithin
24 h (Fig. 4C). Compared with gp130fl/fl littermates, HIL-6-induced
drop in pawwithdrawal latencies was significantly attenuated in the
nociceptor-specific SNS-gp130/mice (Fig. 4D), suggesting that a
major part of HIL-6-induced heat hyperalgesia requires gp130 ex-
pressed in the membrane of nociceptor terminals or axons. Only a
minor part of the sensitizationwas found to be independent of neu-
ronal gp130, and could result potentially froma release of secondary
inflammatory mediators from other gp130-expressing cell types,
e.g., those cytokines which signal via gp130-independent receptors,
such as the oncostatinM receptor (OSM-R) and the interleukin-27
receptor WSX-1 (Scheller et al., 2005). Based on the magnitude of
changes observed in the above experiments, we propose that IL-6 is
one of themost important cytokines in this respect. Consistent with
Figure 2. Normalmorphology of sensory ganglia andperipheral nerve in SNS-gp130/.A,B, Distributions of IB4 and CGRP immu-
noreactivityweresimilar inDRGsectionsobtainedfromgp130 fl/flandSNS-gp130/mice.Percentagesof IB4-orCGRP-immunoreactive
neurons in DRG sections were also comparable for the twomouse strains. This indicates that peptidergic and nonpeptidergic small-size
neuronpopulationswere ingeneralnormal in theSNS-gp130/mice.All experimentswere repeated inat least3animals.C,D, Electron
microscopyonnonmyelinatednerve fibers of saphenousnervesofgp130 fl/fl control andSNS-gp130/miceat theageof4–6months.
Asterisks demarcate nonmyelinated axons; arrows point to cytoplasmic processes of the nonmyelinating Schwann cells. Dark structures
surrounding larger caliber axons aremyelin sheaths. Note that therewere nopathological alterations in themutant nerves.
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the above, pain sensitivity has been reported
to be attenuated in mice lacking IL6 or in
wild-type mice after neutralization of en-
dogenous IL-6 (Ferreira et al., 1993; Xu et
al., 1997; Murphy et al., 1999). Further-
more, we observed that other cytokine
activators of gp130, such as leukemia in-
hibitory factor (LIF), neither induced heat
hypersensitivity in vivo nor sensitized no-
ciceptive neurons in vitro (supplemental
Fig. 5, available at www.jneurosci.org as
supplemental material).
Further evidence for a critical role for
IL-6 in the phenotype observed in SNS-
gp130/ mice was found in the following
experiments. In the skin-nerve prepara-
tion, application ofHIL-6 (1 ng/ml) to the
receptive field of unmyelinated heat-
sensitive fibers induced a significant aug-
mentation of responses to a standard
ramp-shaped heat stimulus in 64% (7/11)
of heat-sensitive C-fibers in gp130 fl/flmice
(Fig. 4E; mean discharge 2.01 
 0.42
imp/s before vs 4.17 
 0.72 imp/s after
HIL-6; p 0.01; paired t test). This sensi-
tization occurred within 5 min after
HIL-6 application and was accompanied
by a significant shift of the activation
threshold to a lower temperature
(38.0 
 1.8°C before versus 34.3 

0.9°C 5 min after HIL-6; p 0.05 paired
t test). In contrast, none of the fibers
recorded from SNS-gp130/ mice re-
sponded to HIL-6 with a potentiated
heat response (Fig. 4F; n  7; n.s.; Wil-
coxon rank test). Together, the data
suggest, that gp130 expressed in noci-
ceptors is required for IL-6 to induce
heat hypersensitivity in vivo and heat
sensitization of nociceptors in vitro.
Finally, we performed electrophysiolog-
ical studies in cultured neurons isolated
fromwild-typeDRGs, which directly showed
that HIL-6 sensitizes capsaicin-sensitive neu-
rons to heat stimuli. In particular, we found
a significant increase of heat-activated in-
ward currents after conditioning stimula-
tion with HIL-6 in isolated small diameter
Figure 3. Heat hyperalgesia in pain models required neuronal gp130. A, Changes in heat sensitivity following unilateral
hindpaw injection of CFA in gp130 fl/fl and SNS-gp130/mice. Pawwithdrawal latency in response to ramp heat stimuli applied
to the inflamed area was significantly attenuated at all time points in SNS-gp130/mice (n 18) compared with gp130 fl/fl
(n 17). Asterisks indicate significant differences ( p 0.001, ANOVA) between the two groups. B, In contrast, no difference in
the paw diameters was observed between strains, suggesting that an equal degree of CFA inflammation occurred despite the
deletion of neuronal gp130. C, D, PWL in response to ramp-shaped heat stimuli applied to the plantar side of the hindpaw
ipsilateral () and contralateral (f) to tumor in gp130 fl/fl (C, n 23) and SNS-gp130/ (D, n 17) mice. After tumor
induction in gp130 fl/fl mice, paw withdrawal latency decreased significantly ( p  0.05, ANOVA), starting from day 1 after
injection and persisted over the 10 d of investigation. Mice with sensory neuron-specific deletion of gp130 developed significant
4
heat hypersensitivity only on day 8 after tumor induction. As-
terisks indicate significant differences ( p 0.001) between
ipsilateral and contralateral paw. E, F, Discharge profiles of
heat-sensitive C-fibers innervating the dorsal site of the hind-
paw recorded in an in vitro skin-nerve preparation from
gp130 fl/fl (E) and SNS-gp130/ (F ) mice. Mean discharge
rates in heat-sensitive C-fibers from gp130 fl/fl tumor mice
(n 8) were significantly higher compared with those from
control (naive) mice (E, n 12, p 0.05, ANOVA). Tumor
induction in SNS-gp130/mice did not affect the discharge
rates of the heat-sensitive fibers (F, p  0.05, ANOVA). G,
Weights of plantar and dorsal tumors were similar in mutant
and floxed mice (n.s., not significant).
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DRG neurons (Fig. 4G,H), which was ac-
companied by a shift of activation thresh-
olds toward lower temperatures.
IL-6-induced signaling in
sensory neurons
We then sought to clarify the major sig-
naling components underlying the strik-
ing functional role we observed for gp130
in pain modulation. The capsaicin- and
heat-sensitive ion channel TRPV1, a mem-
berof theTRP(transient receptorpotential)
family of ion channels serves as molecular
transducer at the nociceptive nerve termi-
nals (Caterina et al., 1997; Scott and
Zuker, 1998; Julius and Basbaum, 2001;
Minke and Cook, 2002; Montell, 2005),
and there is ample evidence that TRPV1
regulation by inflammatory mediators is
essential for the generation of heat hyper-
algesia (Davis et al., 2000; Chuang et al.,
2001). We hypothesized that TRPV1
could be regulated by gp130 signaling.
TRPV1 is activated not only by heat
stimuli but also by capsaicin, the pun-
gent ingredient of hot chili peppers, and
in small-sized neurons, HIL-6 induced a
fast and transient potentiation of capsaicin-
activated ionic currents (Icaps) from
1.04 
 0.34 nA before to 1.82 
 0.07 nA
after HIL-6 (Fig. 5A; supplemental Fig. 6,
available at www.jneurosci.org as supple-
mental material). A similar increase of
Icaps was also obtained after conditioning
stimulation of gp130 fl/fl neurons with re-
combinant IL-6 (Fig. 5B), suggesting that
IL-6 binding receptor  subunits are also
expressed in the nociceptive cell mem-
brane. This is in contrast to the rat in
which the sensitizing effect of IL-6 re-
quires soluble IL-6 receptor (Obreja et al.,
2005). Expectedly, the conditioning effect
of IL-6 was fully abrogated in neurons
lacking the gp130 protein from SNS-
gp130/ mice (Fig. 5B). Using capsaicin-
induced excitatory inward currents as a
read-out, we addressed the underlying
signaling pathway and proposed a role of
Gab1/Gab2, PI3K and PKC- (Heinrich et
al., 2003).We performedWestern blot ex-
periments with phosphospecific antibod-
ies, which revealed that adapter proteins
Gab1, Gab2 (Nishida et al., 1999), and
PI3K are phosphorylated in DRG neurons
after stimulation with HIL-6 (Fig. 5C). In
Figure 4. IL6-induced heat hyperalgesia and significance of neuronal gp130. A, IL-6 mRNA was expressed in tumors of both
mouse strains but absent in LL2 cell cultures; and B, IL-6 levels (in pg cytokine/mg protein) were significantly higher in tumor
homogenates (plantar and dorsal) comparedwith control tissue (muscle and spinal cord) isolated from 11mice. C,D, Intraplantar
injectionofHIL-6 (1g in 10l) ingp130 fl/fl (n8) and SNS-gp130/mice (n10) evokedadropof PWL in response toheat
stimulation. Asterisks indicate the data points at which a significant difference ( p 0.001, ANOVA) between the ipsilateral ()
and contralateral (f) side was observed. PWL decreased to significantly lower values in gp130 fl/fl (n  8) compared with
SNS-gp130/ mice ( p 0.01, ANOVA, n 10). E, F. Discharge profiles of heat-sensitive C-fibers before and after HIL-6 (1
ng/ml) application on the receptive fields in an in vitro skin-nerve preparation from gp130 fl/fl (E) and SNS-gp130/ (F) mice.
HIL-6 application for 5 min induced a significant increase in the mean rate of discharge of the heat C-nociceptors from gp130 fl/fl
4
(E, p 0.01, paired t test, n 7). Heat-sensitive C-fibers
from SNS-gp130/ mice were not affected by HIL-6
stimulation (F, p 0.05, Wilcoxon rank test, n 7). G, H,
Iheat was significantly facilitated after HIL-6 (H), and the
increase in peak current amplitudes was accompanied by a
shift in activation threshold temperature (G).
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the presence of wortmannin (1 M), a
PI3K inhibitor, HIL-6 no longer in-
duced a sensitization of Icaps (Fig. 5D)
suggesting that PI3K was involved in the
signaling cascade downstream of gp130
in nociceptive neurons. It is known that
protein kinase C (PKC) can be recruited
on PI3K activation in SK-N-BE cells (Plo
et al., 2004) and translocation of PKC
from a cytosolic to a membrane-
associated location within the cell is a
sensitive indicator of PKC activation. In
rat DRG sensory neurons, both PKC-
and PKC- are clearly translocated to the
surface membrane on treatment with the
PKC activator phorbol-12-myristate-13-
acetate (PMA) (Cesare andMcNaughton,
1996). Since PKC- has been associated
with PI3K activation, we investigated
whether this isoform was translocated
following exposure to HIL-6. In un-
treated neurons of both gp130fl/fl and
SNS-gp130/ mice, PKC- was distrib-
uted uniformly throughout the cyto-
plasm. Stimulation with HIL-6 caused an
activation of PKC-, which was visible as
redistribution from the cytosol to the cell
membrane. In contrast, no migration of
PKC- was observed in sensory neurons
of mutant mice (Fig. 5E,F ). In line with
the translocation of PKC-, both the
nonselective PKC inhibitor BIM-1 (data
not shown) and the PKC- inhibitor
Rottlerin (Gschwendt et al., 1994) sig-
nificantly reduced or abolished the HIL-
6-induced facilitation of Icaps (Fig. 5G).
Together, these data suggest a gp130-
mediated activation of PKC- via Gab1/
2/PI3K, and consecutive regulation of heat
and capsaicin activated ion currents.
The phenotypic alterations seen in
SNS-gp130/ (lack of heat hypersensi-
tivity in pathological pain models) and
the involvement of PKC prompted us to
address the potential modulation of
TRPV1 by gp130 signaling in sensory
neurons. After HIL-6 injection, wild-
type mice reacted with a significant drop in PWL from 15.21

0.91 s before the injection to 5.10
 0.77 s after 1 h ( p 0.001;
Student’s t-Test, n  6), which recovered to preinjection val-
ues within 24 h. In TRPV1/mice, the drop in PWL was signif-
icantly attenuated (15.44 
 1.51 s before the injection vs 10.43 

0.62 s after 1 h) (Fig. 5H). One hour after HIL-6 injection wild-type
littermates showed a significant drop in PWL in comparison with
TRPV1/mice (5.10
0.77 s inwtvs10.43
0.62 s inTRPV1/;
p 0.001; Mann–Whitney Rank Sum Test, n 6). These experi-
ments suggest thatTRPV1plays amajor role inHIL-6–inducedheat
hypersensitivity in vivo and revealed that sensitization of nociceptive
neurons toheatwasdue toa regulationofTRPV1.Thisdidnot result
fromdifferences inTRPV1expressionpatterns sincemRNAanalysis
using quantitative PCR revealed that TRPV1mRNAexpression lev-
els were similar in the mutant mouse and the wild type (data not
shown).
Discussion
Together, our data suggest that gp130 expressed in themembrane
of nociceptive primary afferents is critically required for the de-
velopment of pathological pain and hyperalgesia in inflamma-
tory conditions as well as in cancer. We observed that deletion of
gp130 specifically in sensory nerves alleviates heat hyperalgesia in
vivo in models of pathological pain with inflammatory background
independently of an anti-inflammatory action ormodulation of tu-
mor growth. Our results show that the gp130-Gab1/Gab2-PI3K-
PKC--TRPV1 pathway in peripheral sensory neurons is a novel
molecular pathway linking inflammatory cytokines to pain
hypersensitivity.
IL-6 and IL-6-related cytokines share a common signaling
receptor subunit gp130 which is ubiquitously expressed in the
cellular membrane of all cells types. In contrast to IL-6 the other
members of the cytokine group, such as LIF, OSM, CNTF, and
Figure 5. Downstream signaling of IL-6/gp130 via Gab1/2, PI3K and PKC-. A, B, Capsaicin-induced ionic currents were tran-
siently and significantly facilitated by HIL-6. C, HIL-6 induced phosphorylation of the adapter proteins Gab1 and Gab2 and PI3K,
respectively. D, The facilitation of Icaps was dose-dependently inhibited by the PI3K inhibitor wortmannin (n 6). E, Stimulation
of neurons with HIL-6 resulted in a translocation of PKC- toward the plasmamembrane in neurons from gp130 fl/fl but not from
SNS-gp130/mice. F, To quantify PKC- translocation, fluorescence intensities weremeasured at the periphery and the center
of the cell by performing a confocal line scan. The ratio k of the twowas then calculated as detailed inMaterials andMethods: k
1,no translocation;k1, translocation to thePM;k1, cytoplasmic localizationofPKC-.G, The facilitationof Icapswas inhibited
by the PKC- inhibitor rottlerin (n 6).H, The drop in PWL after HIL-6 injection was significantly attenuated in TRPV1/mice
compared with wt littermates (n 6).
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CT-1, can heterodimerize also with other membrane-bound re-
ceptor subunits. The common signaling molecule gp130 is ubiq-
uitously expressed, whereas IL-6R is not (Peters et al., 1998).
Therefore, a majority of cell types, including neurons, require
the additional presence of soluble IL-6 receptor (Rose-John and
Heinrich, 1994; Ma¨rz et al., 1999; Opre´e and Kress, 2000).
Application of HIL-6 led to a significant increase in heat re-
sponses and a decrease of the activation temperature, which de-
pended on neuronal gp130. The sensitization process occurred at
short latency, which suggests the involvement of a fast signaling
cascade, rather than the classical cytokine-induced activation of
the Janus kinase/signal transducer and activator of transcription
pathway, the RAS/mitogen-activated protein kinase pathway and
changes in gene expression. The present data favor a gp130
receptor-mediated activation of protein kinases and the consec-
utive phosphorylation of a heat transducing ion channel, i.e., the
heat-transducing vanilloid receptor TRPV1 (Caterina et al.,
1997). TRPV1 in its function as a molecular temperature sensor
at the cell surface (Julius and Basbaum, 2001) seems to be a likely
candidate regulated by IL-6 signaling via PKC-dependent phos-
phorylation. Inflammatory mediators activating PKC sensitize
TRPV1 (Cesare and McNaughton, 1996; Cesare et al., 1999;
Premkumar and Ahern, 2000; Sugiura et al., 2002) and PKC ini-
hbitors attenuate the sensitization of heat-activated inward cur-
rents by IL-6/gp130 (Obreja et al., 2005). Recent evidence
supports the specific involvement of the calcium-independent
isoform PKC- in IL-6/gp130 signal transduction (Jain et al.,
1999; Novotny-Diermayr et al., 2002). Indeed, we observed
translocation of PKC- after stimulating sensory neurons with
IL-6 and IL-6-induced increases in Icaps were significantly re-
duced in the presence of the rottlerin, which inhibits PKC- in
neurons (Zhang et al., 2007) but which may have additional ef-
fects (Soltoff, 2007). The structure of TRPV1 exhibits several in-
tracellular phosphorylation sites comprising targets for protein
kinases like PKA, PKC or PTK (Vellani et al., 2001; Bhave et al.,
2002, 2003; Rathee et al., 2002; Jin et al., 2004; Jung et al., 2004;
Zhang et al., 2005; Mandadi et al., 2006), and phosphorylation at
these sites leaves the channel in a state of increased activity
(Numazaki et al., 2002; Mohapatra and Nau, 2003; Mandadi et
al., 2006). Additionally, PKC has been shown to regulate exocy-
tosis of TRPV1 channels preformed in cytosolic vesicles into the
plasma membrane (Morenilla-Palao et al., 2004) which could
cooperate with the sensitization of phosphorylated channel pro-
teins to explain enhanced neuron sensitivity. Our results extend
these findings, and we now provide a novel signaling pathway of
IL-6/gp130-induced regulation of TRPV1 via activation Gab1/
Gab2, PI3K and PKC-. PI3K has been reported to mediate the
early induction of hyperalgesia and also can sensitize TRPV1,
possibly through posttranslational modification (Zhuang et al.,
2004). Itmay also indirectly regulate the activity of the channel by
upregulating its translation or trafficking (Stein et al., 2006). Pre-
viously it has been shown that PI3K rapidly activates intracellular
protein kinases, like PKB/Akt, and some isoforms of PKC like
PKC- (Balendran et al., 2000; Plo et al., 2004; Zhuang et al.,
2004; Zhu and Oxford, 2007). We demonstrate here that this
pathway is activated in sensory neurons. Gp130-mediated activa-
tion of PKC- was indicated by a significant translocation to the
cellmembrane and thus increased proximity to ion channels with
sensory function. Precisely this relocation of PKC isoforms has
been shown to regulate TRPV1 via phosphorylation and translo-
cation into the plasma membrane, both of which occur at a fast
time scale (Morenilla-Palao et al., 2004; Premkumar et al., 2004;
Zhang et al., 2005; Mandadi et al., 2006). Apart from the regula-
tion of TRPV1, IL-6-dependent activation of PKC- can interact
with STAT3, and this enhances the interaction of STAT3with the
gp130 receptor which is the initial step for STAT3 activation by
IL-6 (Novotny-Diermayr et al., 2002). In hematopoietic stem
cells, IL-6 regulates expression ofmembrane-bound and -soluble
IL-6R subunits (Campard et al., 2006). Such effects might also
contribute to the IL-6-induced nociceptor sensitization and
likely further promote TRPV1 regulation downstreamof gp130
activation. IL-6R can exist as a soluble protein (sIL-6R), which
binds the ligand IL-6. This soluble complex can bind to gp130 on
cells that lack the membrane-bound IL-6R and initiate signaling.
The significance of this so called trans-signaling via sIL-6R is
generally accepted and very likely exceeds the significance of the
membrane-bound IL-6R (for review, see Jones and Rose-John,
2002; Rose-John et al., 2006). Surprisingly, the sIL-R6 was not
essentially required in our cellular model, and this is in contrast
to previous work in the rat (Obreja et al., 2002a, 2005). It is the
general assumption that in many human tissues sIL-6R acts as an
agonist in combination with IL-6 resulting in an enhancement of
the IL-6 effects, however, sIL-6R may have IL-6-antagonistic ef-
fects (for review, see Knu¨pfer and Preiss, 2008).
In inflammation and cancer, IL-6 biology is coordinated by
membrane-bound and -soluble receptors (Rose-John et al.,
2006). Not only in a mouse model of peripheral inflammation
alone, but also in a mouse cancer pain model, we observed a
major contribution of gp130 expressed on sensory nerves in hy-
peralgesia, independently of its role in inflammation and tumor
growth per se. Both models are characterized by inflammatory
changes and activation of immune cells secreting proinflamma-
tory cytokines, such as IL-6 (Constantin et al., 2008). In clinical
trials, treatment of patients suffering from rheumatoid arthritis
and inflammatory pain with a neutralizing anti-IL-6R antibody
was reported to ameliorate symptoms of inflammation as well as
the associated pain (Smolen et al., 2008). Our results uncover the
significance of gp130 expressed in peripheral pain sensing neu-
rons in the pathophysiology of major clinical pain disorders and
suggest its promise as a novel therapeutic target.
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